Advocacy Letter
March 7, 2022: MGMA and coalition partners respond to Medicare Advantage RFI related to prior authorization
March 7, 2022
Re: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (“Proposed Rule”)
Dear Administrator Brooks-LaSure:
The Regulatory Relief Coalition (RRC) appreciates the opportunity to comment on the above-referenced Proposed Rule. The RRC is a group of national physician specialty organizations advocating for regulatory burden reduction in Medicare so that physicians can spend more time treating patients. We aim to ensure that prior authorization (PA) is not a barrier to timely access to care for the patients we serve.
Explore Related Content

Webinar
2026 Medicare Outlook

Federal Policy Resource
Status of Medicare Telehealth Waivers

Sponsored Solution
Value-Based Care and Heart Failure: Evidence on GDMT Adherence

Federal Policy Resource
Implementing the No Surprises Act

Federal Policy Resource
MIPS APM Performance Pathway
More Advocacy Letters

Advocacy Letter
(Nov 13, 2025) MGMA Seeks WISer Reform





















